The Australian Medical Research and Innovation Strategy (Strategy) is determined by the Australian Medical Research Advisory Board (AMRAB). The Strategy ensures a coherent and consistent approach is adopted in the funding of medical research and innovation from the Medical Research Future Fund (MRFF). The current Strategy covers the period 2016-2021, with the next Strategy (2021-2026) to be registered before 8 November 2021.

The Medical Research Future Fund Act 2015 (MRFF Act) required AMRAB to undertake a consultation process before determining a Strategy. The consultation opened on 20 September 2021 and ended on 11 October 2021.

This consultation was an opportunity to ensure that an updated Strategy is meeting its purpose as described in the MRFF Act, accounting for critical current and future issues and factors (e.g. primary prevention), and will continue to allow the MRFF to fund research to address national health priorities and deliver practical benefits from medical research and medical innovation to Australians.

The Consumers Health Forum of Australia (CHF) is the national peak body representing the interests of Australian healthcare consumers and those with an interest in health consumer affairs, including health-based research. We have over 250 members reflecting a broad spectrum of organisations including state-based consumer peaks, condition-specific groups, volunteer patient groups, professional associations, Primary Health Networks (PHNs) and the research community.

We work in collaboration with our members, national partners and research collaborators to influence policy, programs and services to ensure they are in the consumer and community interest. CHF is pleased to make this submission in to this AMRAB Consultation on developing the MRFF 2021-2026 Strategy.

Note that this consultation was administered as an online survey and this document has been adapted from the CHF submission to that survey.


Publication type: 
Publish date: 
Monday, October 11, 2021